Literature DB >> 7448609

Continuous ketamine infusion for one-lung anaesthesia.

A I Weinreich, G Silvay, P D Lumb.   

Abstract

The mechanism which normally affects distribution of blood flow through unventilated areas of the lung is hypoxic pulmonary vasoconstriction; this acts to divert the blood to well ventilated alveoli, resulting in a better ratio of ventilation to perfusion. Several reports have focused attention on the reduction or abolition of this reflex in the unventilated lung by most of the volatile anaesthetic agents used in clinical practice. This response was not abolished by the intravenous anaesthetic agents. One hundred and ten patients undergoing elective pulmonary resection were studied to evaluate the effect of a continuous infusion of ketamine during one-lung anaesthesia, by observing the changes in PaO2 as a reflection of shunt. Ketamine was chosen as the intravenous agent for its positive inotropic and chronotropic action. Additionally, by providing both analgesia and hypnosis, we were able to administer inspired oxygen concentrations of 50-100 per cent without concern that the patient might have recall for events during operation. We have demonstrated that in all cases a PaO2 in excess of 9.31 kPa (70 torr) was achieved with ketamine and FIO2 1.0 as well as an increase in shunt fraction from 25.9 per cent (FIO2 0.5) to 36.0 per cent (FIO2 1.0). We feel that ketamine provides a satisfactory alternative to the volatile agents for one-lung anaesthesia in patients where relative hypoxaemia might be unacceptable during operation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7448609     DOI: 10.1007/bf03007049

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  34 in total

1.  Pharmacokinetics of ketamine in man.

Authors:  J Wieber; R Gugler; J H Hengstmann; H J Dengler
Journal:  Anaesthesist       Date:  1975-06       Impact factor: 1.041

2.  The effects of halothane on myocardial contractile force and vascular resistance. Direct observations made in patients during cardiopulmonary bypass.

Authors:  D H MORROW; A G MORROW
Journal:  Anesthesiology       Date:  1961 Jul-Aug       Impact factor: 7.892

3.  Arterial oxygenation during artificial ventilation. The effect of airway closure and of its prevention by positive end-expiratory pressure.

Authors:  G S McCarthy; G Hedenstierna
Journal:  Acta Anaesthesiol Scand       Date:  1978       Impact factor: 2.105

4.  Evaluation of a new method for the continuous measurement of the distribution of the blood flow between the two lungs.

Authors:  M K Sykes; A E Hill; L Loh; A R Tait
Journal:  Br J Anaesth       Date:  1977-04       Impact factor: 9.166

Review 5.  Blood flow to the lung and gas exchange.

Authors:  J B West
Journal:  Anesthesiology       Date:  1974-08       Impact factor: 7.892

6.  Abdominal and thoracic surgery in adults with ketamine, nitrous oxide, and d-tubocurarine.

Authors:  R W Vaughan; C R Stephen
Journal:  Anesth Analg       Date:  1974 Mar-Apr       Impact factor: 5.108

7.  Airway closure, gas trapping, and the functional residual capacity during anesthesia.

Authors:  H F Don; W M Wahba; D B Craig
Journal:  Anesthesiology       Date:  1972-06       Impact factor: 7.892

8.  Hypoxia and pulmonary vascular resistance. The relative effects of pulmonary arterial and alveolar PO2.

Authors:  A Hauge
Journal:  Acta Physiol Scand       Date:  1969 May-Jun

9.  A comparison of the effects of continuous ketamine infusion and halothane on oxygenation during one-lung anaesthesia in dogs.

Authors:  P D Lumb; G Silvay; A I Weinreich; H Shiang
Journal:  Can Anaesth Soc J       Date:  1979-09

10.  Phagocytosis during general anesthesia in man.

Authors:  B F Cullen; R B Hume; P B Chretien
Journal:  Anesth Analg       Date:  1975 Jul-Aug       Impact factor: 5.108

View more
  2 in total

1.  Predicting arterial oxygenation during one-lung anaesthesia.

Authors:  P Slinger; S Suissa; W Triolet
Journal:  Can J Anaesth       Date:  1992-12       Impact factor: 5.063

Review 2.  Ketamine: an update on the first twenty-five years of clinical experience.

Authors:  D L Reich; G Silvay
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.